Terms: = Breast cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Prognosis
61 results:
1. Characteristics and outcome of systemic treatment for metastatic or unresectable thymic carcinoma: A single institution experience.
Ho IW; Pan YL; Lai JI; Liu CY
Thorac Cancer; 2024 Feb; 15(4):339-346. PubMed ID: 38149471
[TBL] [Abstract] [Full Text] [Related]
2. brd4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells.
Kim SL; Choi HS; Lee DS
Cell Commun Signal; 2023 Nov; 21(1):315. PubMed ID: 37924094
[TBL] [Abstract] [Full Text] [Related]
3. The Usefulness of Elastin Staining to Detect Vascular Invasion in cancer.
Gonzalez J; Bahmad HF; Ocejo S; Abreu A; Popp M; Gogola S; Fernandez V; Recine M; Poppiti R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894944
[TBL] [Abstract] [Full Text] [Related]
4. Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study.
Lopez-Tarruella S; Del Monte-Millán M; Roche-Molina M; Jerez Y; Echavarria Diaz-Guardamino I; Herrero López B; Gamez Casado S; Marquez-Rodas I; Alvarez E; Cebollero M; Massarrah T; Ocaña I; Arias A; García-Sáenz JÁ; Moreno Anton F; Olier Garate C; Moreno Muñoz D; Marrupe D; Lara Álvarez MÁ; Enrech S; Bueno Muiño C; Martín M
Breast Cancer Res Treat; 2024 Jan; 203(1):163-172. PubMed ID: 37773555
[TBL] [Abstract] [Full Text] [Related]
5. Standardized pathology report for HER2 testing in compliance with 2023 ASCO/cap updates and 2023 ESMO consensus statements on HER2-low breast cancer.
Ivanova M; Porta FM; D'Ercole M; Pescia C; Sajjadi E; Cursano G; De Camilli E; Pala O; Mazzarol G; Venetis K; Guerini-Rocco E; Curigliano G; Viale G; Fusco N
Virchows Arch; 2024 Jan; 484(1):3-14. PubMed ID: 37770765
[TBL] [Abstract] [Full Text] [Related]
6. HER-2 overexpression in female genital tract clear cell carcinomas: Evaluation of different scoring guidelines, clinicopathological features and prognostic impact.
Edjtemaei R; Nili F; Jahanzad I; Ameli F; Ghasemi D
Ann Diagn Pathol; 2023 Oct; 66():152184. PubMed ID: 37543027
[TBL] [Abstract] [Full Text] [Related]
7. MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression.
Deng L; Liao L; Zhang YL; Hu SY; Yang SY; Ma XY; Huang MY; Zhang FL; Li DQ
Cancer Lett; 2023 Apr; 560():216124. PubMed ID: 36907504
[TBL] [Abstract] [Full Text] [Related]
8. A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China.
Zhou S; Lv H; Li A; Li M; Zhong S; Lu H; Zhou X; Bai Q; Yang W
BMC Cancer; 2023 Jan; 23(1):84. PubMed ID: 36698078
[TBL] [Abstract] [Full Text] [Related]
9. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract] [Full Text] [Related]
10. Exploration of Aging-Care Parameters to Predict Mortality of Patients Aged 80-Years and Above with Community-Acquired Pneumonia.
Lv C; Shi W; Pan T; Li H; Peng W; Xu J; Deng J
Clin Interv Aging; 2022; 17():1379-1391. PubMed ID: 36164658
[TBL] [Abstract] [Full Text] [Related]
11. Extranodal extension, an international survey on its evaluation and reporting in breast cancer patients.
Tang P; Moravek M; Oprea-Ilies G; Mon KS; Pambuccian SE
Pathol Res Pract; 2022 Sep; 237():154070. PubMed ID: 36030639
[TBL] [Abstract] [Full Text] [Related]
12. Hsa_circRNA_0040462: a sensor of cells' response to cap treatment with double-edged roles on breast cancer malignancy.
Tian Y; Zhang Z; Zhang Z; Dai X
Int J Med Sci; 2022; 19(4):640-650. PubMed ID: 35582416
[TBL] [Abstract] [Full Text] [Related]
13. BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer.
Murthy SRK; Cheng X; Zhuang T; Ly L; Jones O; Basadonna G; Keidar M; Canady J
Sci Rep; 2022 Mar; 12(1):4038. PubMed ID: 35260587
[TBL] [Abstract] [Full Text] [Related]
14. Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/cap guideline.
Kong H; Bai Q; Li A; Zhou X; Yang W
Diagn Pathol; 2022 Jan; 17(1):5. PubMed ID: 34996485
[TBL] [Abstract] [Full Text] [Related]
15. Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes.
Jafari N; Kolla M; Meshulam T; Shafran JS; Qiu Y; Casey AN; Pompa IR; Ennis CS; Mazzeo CS; Rabhi N; Farmer SR; Denis GV
Sci Signal; 2021 Nov; 14(710):eabj2807. PubMed ID: 34813359
[TBL] [Abstract] [Full Text] [Related]
16. The prognostic and predictive impact of low estrogen receptor expression in early breast cancer: a systematic review and meta-analysis.
Paakkola NM; Karakatsanis A; Mauri D; Foukakis T; Valachis A
ESMO Open; 2021 Dec; 6(6):100289. PubMed ID: 34678571
[TBL] [Abstract] [Full Text] [Related]
17. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway.
Li Y; Wang Z; Su P; Liang Y; Li Z; Zhang H; Song X; Han D; Wang X; Liu Y; Yang J; Chen B; Wang L; Zhao W; Yang Q
Mol Ther; 2022 Jan; 30(1):415-430. PubMed ID: 34450253
[TBL] [Abstract] [Full Text] [Related]
18. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma.
Mao CG; Jiang SS; Wang XY; Tao SL; Jiang B; Mao CY; Yang YL; Hu ZY; Long T; Jin H; Tan QY; Huang Y; Deng B
Int J Biol Sci; 2021; 17(10):2461-2475. PubMed ID: 34326687
[No Abstract] [Full Text] [Related]
19. Bromodomain-containing Protein 4 Is a Favourable Prognostic Factor in breast cancer Patients.
Suzuki C; Yamada A; Adachi S; Shima H; Kida K; Oshi M; Sugae S; Yamamoto S; Narui K; Tanabe M; Takabe K; Ichikawa Y; Ishikawa T; Endo I
Anticancer Res; 2021 Jul; 41(7):3597-3606. PubMed ID: 34230156
[TBL] [Abstract] [Full Text] [Related]
20. The targetable nanoparticle BAF312@cRGD-cap-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
[TBL] [Abstract] [Full Text] [Related]
[Next]
